Xue-biao Wei

Dr. Xue-biao Wei

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2023 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
YNYuxin Nong
Yuxin Nong
XWXue-biao Wei
Xue-biao Wei
DYDan-qing Yu
Dan-qing Yu
Sepsis‐induced myocardial dysfunction (SIMD) is the leading cause of death in patients with sepsis in the intensive care units. The main manifestations of SIMD are systolic and diastolic dysfunctions of the myocardium. Despite our initial understanding of the SIMD over the past three decades, the incidence and mortality of SIMD remain high. This may be attributed to the large degree of heterogeneity among the initiating factors, disease processes, and host states involved in SIMD. Previously, organ dysfunction caused by sepsis was thought to be an impairment brought about by an excessive inflammatory response. However, many recent studies have shown that SIMD is a consequence of a combination of factors shaped by the inflammatory responses between the pathogen and the host. In this article, we review the mechanisms of the inflammatory responses and potential novel therapeutic strategies in SIMD.

12 February 2024 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YNYuxin Nong
Yuxin Nong
GWGuangyu Wu
Guangyu Wu
JLJunquan Lu
Junquan Lu
XWXue-biao Wei
Xue-biao Wei
DYDan-qing Yu
Dan-qing Yu

19 December 2024 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
YNYuxin Nong
Yuxin Nong
JLJunquan Lu
Junquan Lu
DYDan-qing Yu
Dan-qing Yu
XWXue-biao Wei
Xue-biao Wei
Background: Endothelial dysfunction is one of the important mechanisms of organ and tissue damage in sepsis. In this study, we evaluated the effects of neohesperidin dihydrochalone (NHDC) on lipopolysaccharide (LPS)‐induced vascular dysfunction and explored the potential mechanisms.Methods: In vivo, we assessed vascular leakage in mice by injecting Evans blue dye. In vitro, cell counting kit‐8 (CCK‐8) assay and flow cytometry were used to assess the activity of HUVEC and apoptosis. The effect of LPS on HUVEC barrier was assessed using FITC‐extend membrane assay. The adhesion ability of HUVEC was tested by THP‐1 cell adhesion assay. The antioxidant capacity of cells was measured by detecting the level of mitochondrial membrane potential, ROS, and content of CAT, SOD, GSH, and MDA within the cells. Furthermore, the release of endothelial IL‐1β, IL‐6, and TNF‐α were detected by ELISA, and the expression level of TAK1, ERK1/2, and NFκB were detected by western blot.Results: Treatment with NHDC effectively alleviated LPS‐induced endothelial permeability and organ damage by reducing reactive oxygen species production and enhancing the antioxidant response. Further investigation suggested that NHDC may exert its protective effects by inhibiting the release of IL‐1β, IL‐6, and TNF‐α, and by decreasing the phosphorylation of key inflammatory signaling molecules, including transforming growth factor‐β‐activated kinase 1 (TAK1), extracellular signal‐regulated kinases 1/2 (ERK1/2), and nuclear factor kappa B (NFκB).Conclusions: Our study indicate that pretreatment with NHDC may provide protection against LPS‐induced vascular dysfunction by reducing oxidative stress and activation of inflammatory signaling pathways.

1 January 2026 in Theranostics
Verified
Journal Article
Open access
PDF file
THTianhao Huang
Tianhao Huang
CHChonghui Hu
Chonghui Hu
HCHuimou Chen
Huimou Chen
HJHonghui Jiang
Honghui Jiang
TLTingting Li
Tingting Li
SZShangyou Zheng
Shangyou Zheng
Background: Perineural invasion (PNI) is a key biological feature underpinning the high malignancy and poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Lysine lactylation (Kla), a metabolite-stress-induced post-translational modification, plays crucial regulatory roles in diverse biological processes. The RNA methyltransferase NSUN2 is essential for cancer invasion and metastasis. However, the mechanisms by which NSUN2 contributes to lactylation-driven PNI in PDAC remain to be elucidated.

29 January 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
XWXue-biao Wei
Xue-biao Wei
ZWZhong-Hua Wang
Zhong-Hua Wang
XLXiao-Long Liao
Xiao-Long Liao
WGWei-Xin Guo
Wei-Xin Guo
TQTiehe Qin
Tiehe Qin
SWShou-hong Wang
Shou-hong Wang
Background: The therapeutic role of neuromuscular blocking agents (NMBA) in patients with acute respiratory distress syndrome (ARDS) remains controversial. Methods: We systematically reviewed randomized controlled trials investigating the use of NMBA in ARDS patients from inception to July 2019. Relative risk (RR) was calculated for the incidence of barotrauma and mortality using the random-effect or fixed-effect model according to heterogeneity analysis. Results: Data were combined from five randomized controlled trials that included 1,461 patients (724 in the NMBA group and 737 in the control group). Pooled analysis showed that NMBA infusion did not reduce 28-day mortality (RR = 0.72, 95% confidence interval (CI) 0.44 to 1.17, P=0.180, I-squared = 62.8%), but was associated with lower intensive care unit (ICU) mortality (RR = 0.60, 95% CI 0.41 to 0.88, P = 0.009, I-squared = 9.2%). In addition, the incidence of barotrauma was significantly lower in patients treated with NMBA (RR = 0.53, 95% CI 0.33 to 0.84, P = 0.007, I-squared = 0). However, infusion of NMBA might increase the risk of ICU-acquired weakness (RR = 1.34, 95% CI 0.97 to 1.84, P = 0.066, I-squared = 0). Conclusion: Infusion of NMBA could reduce ICU mortality and the incidence of barotrauma. The risk of ICU-acquired weakness was higher in moderate-to-severe ARDS patients treated with NMBA. The real effects of NMBA need to be further evaluated and confirmed by a study with a stricter design.

6 June 2022 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
MJMei Jiang
Mei Jiang
XWXue-biao Wei
Xue-biao Wei
JHJie-Leng Huang
Jie-Leng Huang
ZSZe-Da-Zhong Su
Ze-Da-Zhong Su
YLYing-Wen Lin
Ying-Wen Lin
DYDan-qing Yu
Dan-qing Yu
Resumo Fundamento: A disfunção hepática é uma variável postulada de prognóstico desfavorável na cardiomiopatia dilatada (CMD). Objetivo: Este estudo teve como objetivo investigar o valor prognóstico do escore albumina-bilirrubina (ALBI), um modelo relativamente novo para a avaliação da função hepática, em pacientes com CMD idiopática. Métodos: Um total de 1.025 pacientes com CMD idiopática foram incluídos retrospectivamente e divididos em três grupos com base nos escores de ALBI: grau 1 (≤ −2,60, n = 113), grau 2 (−2,60 a −1,39, [...] Resumo Fundamento: A disfunção hepática é uma variável postulada de prognóstico desfavorável na cardiomiopatia dilatada (CMD). Objetivo: Este estudo teve como objetivo investigar o valor prognóstico do escore albumina-bilirrubina (ALBI), um modelo relativamente novo para a avaliação da função hepática, em pacientes com CMD idiopática. Métodos: Um total de 1.025 pacientes com CMD idiopática foram incluídos retrospectivamente e divididos em três grupos com base nos escores de ALBI: grau 1 (≤ −2,60, n = 113), grau 2 (−2,60 a −1,39,